₹669.6▲1.39%
1.64%
Low
Day's Volatility:1.99%
High
0.36%
30.02%
Low
52 Weeks Volatility:44.71%
High
14.70%
Returns % | |
1 Month Return | 0.22 % |
3 Month Return | 1.2 % |
1 Year Return | 40.55 % |
Market Stats | |
Previous Close | ₹660.45 |
Open | ₹663.90 |
Volume | 1.37L |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹16,812.74Cr |
based on 2 analysts
Based on 2 analysts offering long term price targets for Suven Pharmaceuticals Ltd. An average target of ₹685.5
Source: S&P Global Market Intelligence
Organisation | Suven Pharmaceuticals Ltd |
Headquarters | |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Key events for Suven Pharmaceuticals Ltd
Goldman Sachs India Equity fund has acquired a 1.11% stake in Suven Pharmaceuticals for Rs. 119.1 crore. The company's Q3 FY23-24 revenue from operations declined by nearly 37.8%, accompanied by a fall in net profit of 56.5%. However, the stock has delivered positive returns of about 15.8% in the last six months and nearly 41.4% in the last one year.
Goldman Sachs India Buys 1.11% Stake in Suven Pharmaceuticals - 20 Apr, 2024
Goldman Sachs India has purchased a 1.11% stake in Suven Pharmaceuticals Ltd as of March 2024, with the company reporting revenue of Rs 220 crore and net profit of Rs 47 crore in Q3FY24.
Advent Looks to Take Advantage of China+1 Wave for Suven Pharma - 17 Apr, 2024
Private equity firm Advent, which merged Suven Pharma with Cohance Lifesciences in February, aims to leverage the China+1 wave and other geopolitical tailwinds. India's pharma outsourcing edge is limited by the scale of local contract manufacturers compared to global rivals from China and Europe.
Suven Pharma Underperforms Benchmark Indices - 15 Apr, 2024
Suven Pharmaceuticals has underperformed both the NSE Smallcap index and the Nifty Pharma index this year, shedding 13.5%. The company's sub-par earnings in Q3 2023 have contributed to its poor performance.
Fundamentals of Suven Pharmaceuticals Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Retail Holding Up
Retail Investor have increased holdings from 13.91% to 23.10% in Mar 2024 quarter
Price Rise
In the last 3 years, SUVENPHAR stock has moved up by 21.7%
MF Holding Up
Mutual Funds have increased holdings from 13.40% to 15.26% in Mar 2024 quarter
Against Peers
In the last 1 year, Sun Pharmaceuticals Industries Ltd has given 54.4% return, outperforming this stock by 13.8%
Against Peers
In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 127.9% return, outperforming this stock by 106.2%
Promoter Holding Down
Promoters have decreased holdings from 60.00% to 50.10% in Mar 2024 quarter
Profit Down
Netprofit is down for the last 4 quarters, 123.97 Cr → 46.75 Cr (in ₹), with an average decrease of 26.0% per quarter
FII Holding Down
Foreign Institutions have decreased holdings from 10.14% to 9.54% in Mar 2024 quarter
Revenue Fall
Revenue is down for the last 4 quarters, 380.76 Cr → 234.16 Cr (in ₹), with an average decrease of 14.2% per quarter
Suven Pharmaceuticals Ltd in the last 5 years
Lowest (4.48x)
March 30, 2020
Today (45.30x)
April 30, 2024
Industry (62.57x)
April 30, 2024
Highest (51.50x)
January 4, 2024
Investors | Holdings % | Prev. 1 periods | 3M change |
---|---|---|---|
Promoter Holdings | 50.1% | 0.00 | |
Foreign Institutions | 9.54% | 0.00 | |
Mutual Funds | 15.26% | 0.00 | |
Retail Investors | 23.1% | 0.00 | |
Others | 1.99% | 0.00 |
Technicals of Suven Pharmaceuticals Ltd share
News & Events of Suven Pharmaceuticals Ltd
Suven Pharmaceuticals Ltd (SUVENPHAR) share price today is ₹669.6
Suven Pharmaceuticals Ltd is listed on NSE
Suven Pharmaceuticals Ltd is listed on BSE
PE Ratio of Suven Pharmaceuticals Ltd is 45.3
PE ratio = Suven Pharmaceuticals Ltd Market price per share / Suven Pharmaceuticals Ltd Earnings per share
Today’s traded volume of Suven Pharmaceuticals Ltd(SUVENPHAR) is 1.37L.
Today’s market capitalisation of Suven Pharmaceuticals Ltd(SUVENPHAR) is ₹16812.74Cr.
Suven Pharmaceuticals Ltd(SUVENPHAR | Price |
---|---|
52 Week High | ₹768 |
52 Week Low | ₹468.6 |
Suven Pharmaceuticals Ltd(SUVENPHAR) share price is ₹669.6. It is down -12.81% from its 52 Week High price of ₹768
Suven Pharmaceuticals Ltd(SUVENPHAR) share price is ₹669.6. It is up 42.89% from its 52 Week Low price of ₹468.6
Suven Pharmaceuticals Ltd(SUVENPHAR | Returns |
---|---|
1 Day Returns | 9.15% |
1 Month Returns | 0.22% |
3 Month Returns | 1.2% |
1 Year Returns | 40.55% |